コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 the even positioning of nuclei in the mature myofiber.
2 d necrotic region and increased regenerating myofibers.
3 f dystrophin expression in the sarcolemma of myofibers.
4 robustness of the response to denervation of myofibers.
5 the rate of elimination on fast versus slow myofibers.
6 ring calcium sensitivity or cooperativity of myofibers.
7 fuses specifically to type IIb/x fast-twitch myofibers.
8 tivity to facilitate hypertrophy of type IIb myofibers.
9 nflammation or adipogenic replacement of the myofibers.
10 associated with loss of type 2b fast-twitch myofibers.
11 edominantly contained in fast twitch/type II myofibers.
12 flammation and adipogenic replacement of the myofibers.
13 usion of PMO-loaded myoblasts into repairing myofibers.
14 tivated mainly in muscle progenitors and not myofibers.
15 nment of scaffold nanofibers with endogenous myofibers.
16 h fusion of myoblasts to form multinucleated myofibers.
17 tes fusion of exogenous myoblasts to injured myofibers.
18 nonucleated myoblasts to form multinucleated myofibers.
19 e to form multi-layered bundles with aligned myofibers.
20 most enriched in exosomes compared to parent myofibers.
21 he extracellular matrix (ECM) that surrounds myofibers.
22 uch-evoked motility, and highly disorganized myofibers.
23 yofibers fail to grow at the same rate as WT myofibers.
24 n of myoblasts preferentially at the tips of myofibers.
25 pment, myoblasts fuse to form multinucleated myofibers.
26 ith dystrophin at the sarcolemma in skeletal myofibers.
27 ouse by blunting the regeneration of injured myofibers.
28 er of embryonic myosin-positive regenerating myofibers.
29 in the size of MHC IIA positive or high SDH myofibers.
30 functional cytoplasmic volumes in developing myofibers.
31 population of satellite cells/myoblasts and myofibers.
32 nal diversity within multinucleated skeletal myofibers.
33 n in mice in which signaling was targeted in myofibers.
34 se in immunoreactivity surrounding atrophied myofibers.
35 process of myogenic differentiation to form myofibers.
36 ivity inhibits MP fusion and contribution to myofibers.
37 d in cardiac myocytes and oxidative skeletal myofibers.
38 bodies/exosomes marker CD63 in regenerating myofibers.
39 transferases, as a gene enriched in type IIb myofibers.
40 to be sequentially executed in living single myofibers.
41 s seeding-competent amyloid that is toxic to myofibers.
42 ssed by type I and IIa myofibers but not IIb myofibers.
43 Nos1, and structural genes, such as Myl1, in myofibers.
44 erativity, or calcium-ATPase activity in the myofibers.
45 localized at the sarcolemma of regenerating myofibers.
46 rors were, respectively, 0.179 +/- 0.050 for myofiber, 0.049 +/- 0.017 for cross-fiber, and 0.039 +/-
47 hnology for use on whole-mount mouse primary myofibers, a preparation that isolates single myofibers
50 or imaging revealed reduced reorientation of myofiber aggregates during cardiac contraction in patien
51 a more longitudinal orientation of diastolic myofiber aggregates was measured compared with controls.
52 ate myocytes upon muscle damage, forming new myofibers along with self-renewing stem cells in prepara
55 To address this question, a conditional Ctgf myofiber and fibroblast-knockout mouse lines were genera
56 occupy a satellite cell position between the myofiber and its associated basal lamina in Six1 and Six
58 we applied laser wounding to live mammalian myofibers and assessed translocation of fluorescently ta
59 of functional dystrophin protein in skeletal myofibers and cardiac muscle, improvement of muscle bioc
62 ng-related phenotypes in cis within skeletal myofibers and in trans within satellite cells and within
63 ged mice and results from 15-PGDH-expressing myofibers and interstitial cells, such as macrophages, w
64 we investigated skeletal muscle pathology in myofibers and myofibrils isolated from young hetero- and
65 eneration and regeneration of multinucleated myofibers and pathological activation of a variety of ot
66 enerated a new conditional knockout of MR in myofibers and quantified cell-intrinsic mechanistic effe
67 X7(+) cells generated in culture can produce myofibers and self-renew in vitro and in vivo Together,
68 ing, involves coordinate changes in skeletal myofibers and the cells that contact them, including sat
70 gnized myonuclear subtypes within dystrophic myofibers and uncover degenerative and regenerative tran
71 rogenitor stage to terminally differentiated myofibers, and discuss how this knowledge has been appli
72 sarcolemmal disruption compared to Dysf(129) myofibers, and impaired translocation of annexin A6 asso
77 possess fewer myofibers at birth, and those myofibers are reduced in size and have fewer myonuclei a
78 icant increases in muscle mass, showing that myofibers are the direct target for signaling by these l
80 controls, which correlated with decreases in myofiber area, limb strength, and treadmill time/distanc
82 al dyW-/- muscles display the same number of myofibers as wildtype (WT) muscles, but by E18.5 dyW-/-
83 A7(-/-) mice, hindlimb muscles possess fewer myofibers at birth, and those myofibers are reduced in s
84 ove the membrane integrity of the dystrophic myofibers at the time of AAV-U7 injection, mdx muscles w
87 loss of skeletal muscle mass associated with myofiber atrophy or alter a variety of in situ and ex vi
89 diponectin accumulated on plasma membrane of myofibers both in mice and human, and intracellularly co
90 rough mechanisms involving the regulation of myofiber branching, protein synthesis, and the organizat
91 (p < 0.001) and matured into 0.5 mm diameter myofiber bundles with greater 3D cell alignment and high
93 laminin alpha2 surrogates in mature skeletal myofibers, but it increased the number of embryonic myos
94 nalyze the whole transcriptome of individual myofibers by combining single-fiber isolation with Switc
95 rophin-null phenotype were increased ectopic myofiber calcification and altered macrophage infiltrati
96 ure postnatal deletion of Pofut1 in skeletal myofibers can induce aging-related phenotypes in cis wit
97 ng DNA and restored the Dmd reading frame in myofibers, cardiomyocytes, and muscle stem cells after l
98 enhancers specify muscles in accordance with myofiber composition, show little resemblance to culture
102 no alterations in calcium sensitivity of the myofibers, cooperativity, or calcium-ATPase activity in
103 pericyte transplantation recovered losses in myofiber cross-sectional area and the capillary-to-fiber
104 DNF treatment, few changes were seen in mean myofiber cross-sectional areas compared to age-matched n
105 als (24.6 mum(2)/kg; IQR, 21.6-26.0), median myofiber cross-sectional areas normalized to weight and
108 ) was accomplished and histopathology showed myofiber degeneration in 3 HERDA horses and 1 control.
109 e surrounding the plane of dissection showed myofiber degeneration, fat deposition, and reduction of
110 zation studies in human muscle and zebrafish myofibers demonstrate that PYROXD1 localizes to the nucl
115 and grow normally to adulthood with smaller myofiber diameter, diminished physical performance, and
116 ofibers, reduced variance, increased size of myofiber diameters, reduced myofiber immunoglobulin G up
117 scriptional return on a per nuclear basis in myofibers diminishes, which accounts for both the absolu
120 stently associated with the formation of new myofibers during embryonic development, postlarval growt
121 promotes nutrient uptake and catabolism into myofibers during exercise in an osteocalcin-dependent ma
123 t in a pathway that affects the alignment of myofibers during the development of the ventricular sept
124 following transplantation they show superior myofiber engraftment and ability to seed the satellite c
126 ion, we find that individual nuclei within a myofiber establish different local scaling relationships
129 These results suggest that fetal dyW-/- myofibers fail to grow at the same rate as WT myofibers.
132 al muscle construct shows the improvement of myofiber formation, long-term survival, and neuromuscula
133 which is composed of numerous multinucleated myofibers formed by the fusion of progenitor cells durin
134 aggregates, improves muscle force, protects myofibers from the pathology-derived turnover and decrea
135 yzed the differences in the transcriptome of myofibers from young and old mice to validate the effect
136 that Pit1 and Pit2 are essential for normal myofiber function and survival, insights which may impro
138 muscle-targeted Lrrc8a KO mice have smaller myofibers, generate less force ex vivo, and exhibit redu
142 ts for both the absolute reliance developing myofibers have on nuclear accrual to establish size, and
143 reathing rate 2 SMS excitation in transmural myofiber helix angle, mean diffusivity (mean +/- standar
145 d histological assays are available to study myofiber heterogeneity, efficient methods to analyze the
152 ncreased size of myofiber diameters, reduced myofiber immunoglobulin G uptake, and reduced muscle was
153 le strip composed of differentiated skeletal myofibers in a matrix of natural proteins, including fib
156 as a loss of Abl2 leads to excessively long myofibers in the diaphragm, intercostal and levator auri
161 nds of these muscle islands, suggesting that myofibers induce differentiation of tendon cells, which
164 he DMD gene, encoding dystrophin, compromise myofiber integrity and drive muscle deterioration in Duc
165 with either of these genes severely disrupts myofiber integrity and dystrophin localization, suggesti
167 to dystrophic skeletal muscles through both myofiber intrinsic effects on muscle force and downstrea
168 Resealing of tears in the sarcolemma of myofibers is a necessary step in the repair of muscle ti
169 due to fibrotic or adipogenic replacement of myofibers is common in muscle diseases and muscle-reside
174 kinase 2 (Abl2) has a key role in regulating myofiber length, as a loss of Abl2 leads to excessively
177 or necrotic cell death during stages of peak myofiber loss, countering well-supported assumptions of
179 ion did not scale with cell size, as smaller myofibers (<1000 mum(2)) demonstrated the highest transc
181 ve accumulation of Annexin A2 (AnxA2) in the myofiber matrix causes FAP differentiation into adipocyt
182 ized complex is essential for muscle growth, myofiber maturation, and muscle cell survival and that a
183 rent nuclei within the shared cytoplasm of a myofiber may display transcriptional diversity and wheth
184 data suggest that VEGF expressed by skeletal myofibers may directly or indirectly regulate both hippo
187 er individual nuclei within a multinucleated myofiber might respond differentially to DMD pathogenesi
190 lates strongly with their proportion of slow myofibers: muscles with more slow fibers undergo elimina
191 letal muscle to produce movement, individual myofibers must form stable contacts with tendon cells an
192 repair/integrity leads to calcium influx and myofiber necrosis leading to progressive dystrophic dise
193 membrane ruptures and leakiness that induces myofiber necrosis, a subsequent inflammatory response, a
194 ic mice overexpressing Ctss showed increased myofiber necrosis, muscle histopathology, and a function
197 ally, terminally differentiated, postmitotic myofiber nuclei from obese individuals had elevated gamm
198 ormalities and heterogeneity associated with myofiber nuclei, as well as other mononucleated cell typ
199 sferrin-mediated iron uptake by regenerating myofibers occurs independently of systemic iron homeosta
202 This interaction is present in regenerating myofibers of patients with Duchenne muscular dystrophy,
204 Ectopic muscle islands, each composed of myofibers of uniform length and orientation, form within
206 We performed a thorough characterization of myofiber pathology in mdx mice from 2 weeks to 2 years o
207 is study also confirms the existence of slow myofiber-phenotype and provides mechanistic insights int
208 ies have hypothesized the occurrence of slow myofiber-phenotype, and dysregulation of lipid metabolis
209 d with mutations in genes that stabilize the myofiber plasma membrane, such as through the dystrophin
210 hypothesized that VEGF produced by skeletal myofibers plays a role in regulating hippocampal neurona
211 of genes encoding normal cardiac slow-twitch myofiber proteins and pathologically increased expressio
213 scripts are uniformly distributed throughout myofibers, proximity to specialized regions can affect t
215 showed reduced levels of centrally nucleated myofibers, reduced variance, increased size of myofiber
217 eased membrane leakiness and damage owing to myofiber regeneration and enhanced support at the extrac
218 ating muscle-specific gene expression during myofiber regeneration and have revealed a physiological
220 s to decreased muscle fibrosis and increased myofiber regeneration following IR injury, suggesting sh
225 estoration occurs preferentially in areas of myofiber regeneration, where antisense oligonucleotides
228 k of annexin A2 (AnxA2) also results in poor myofiber repair and progressive muscle weakening with ag
229 of AnxA2-deficient muscle we find that poor myofiber repair due to the lack of AnxA2 does not result
230 n muscle repair, which includes facilitating myofiber repair, chronic muscle inflammation and adipoge
234 n the mdx background significantly increased myofiber sarcolemmal membrane stability with greater exp
237 n myotube cultures was sufficient to promote myofiber shrinkage, consistent with enhanced protein cat
238 e, P < 0.0001, N = 5-10/group) and decreased myofiber size (1661 +/- 134 mum(2) vs. 2221 +/- 100 mum(
239 ofiber regeneration after injury and reduced myofiber size decline in the muscular dystrophy model.
241 eosinophil infiltration in association with myofiber size distribution, centralized nuclei, serum cr
244 onstrate that Mettl21e functions to maintain myofiber size through inhibiting proteasome-mediated pro
246 egenerating myofibers were more abundant and myofiber size was larger for wild-type compared with Ica
247 reases in body mass, muscle mass, quadriceps myofiber size, and survival, but other measurements of s
248 skeletal muscle size and strength, decreased myofiber size, increased slow fiber (type 1) density, in
249 muscle differentiation in vitro and skeletal myofiber size, muscle function, adiposity and systemic m
254 n was demonstrated in vivo in mice harboring myofiber-specific deletion of VEGF-A (mVEGF(-/-)) and in
255 e TEAD1-expressing myofiber, suggesting that myofiber-specific TEAD1 overexpression activates a physi
256 his was tested in adult conditional skeletal myofiber-specific VEGF gene-ablated mice (VEGF(HSA-/-) )
257 P extracellular ATP (eATP) released by dying myofibers steadily activates muscle and immune purinergi
260 These findings reinforce the role of elastic myofiber stretch as a growth stimulant at both cellular
261 ropic growth constitutive model with elastic myofiber stretch as the growth stimuli to simulate long-
262 driven by the deviations of maximum elastic myofiber stretch over a cardiac cycle from its correspon
264 usly via signal(s) from the TEAD1-expressing myofiber, suggesting that myofiber-specific TEAD1 overex
265 , including an affinity for the postsynaptic myofiber surface and phagocytosis of nerve terminals.
266 ccessfully triggered glycolytic-to-oxidative myofiber switch, increased functional mitochondrial cont
267 rcise by stimulating glycolytic-to-oxidative myofiber switch, mitochondrial biogenesis and angiogenes
269 Mutant stem cells contribute to hypotrophic myofibers that are not innervated but retain the ability
270 for skeletal muscle, comprised of syncytial myofibers that each accrue hundreds of nuclei during dev
273 injury causes significant alterations to the myofiber through a muscle stem cell-mediated accumulatio
275 chondrial content per myonucleus in ischemic myofibers to compensate for impaired mitochondrial funct
277 ecialized transcriptional programming within myofibers, tracking activation-induced transcriptional c
278 ent RNA, we measured a sevenfold increase in myofiber transcription during early hypertrophy before a
279 te transcription during hypertrophy and that myofiber transcription is responsive to DNA content but
281 dystrophy pathogenesis that included reduced myofiber turnover and histopathology, reduced fibrosis,
282 he other hand, cellular localization of slow myofiber-type genes revealed their increased expression
291 n contrast, a decrease in myonuclear domain (myofiber volume/myonucleus) was observed regardless of m
293 scle structure after injury, as regenerating myofibers were more abundant and myofiber size was large
294 e, and respiration assessed in permeabilized myofibers were not significantly altered in response to
295 n immature myotubes and fully differentiated myofibers, where it forms ectopic MT organizing centers,
299 yofibers, a preparation that isolates single myofibers with their associated muscle stem cells remain
300 of Mettl21e in mice reduced the size of IIb myofibers without affecting the composition of myofiber
301 low succinate dehydrogenase (SDH) expressing myofibers, without a change in the size of MHC IIA posit